Imperva (IMPV) Lifted to “Buy” at BidaskClub

BidaskClub upgraded shares of Imperva (NASDAQ:IMPV) from a hold rating to a buy rating in a report issued on Tuesday morning.

Several other equities research analysts have also recently weighed in on IMPV. Zacks Investment Research cut shares of Imperva from a strong-buy rating to a hold rating in a research report on Wednesday, April 11th. DA Davidson began coverage on shares of Imperva in a research report on Tuesday, April 10th. They issued a buy rating and a $56.00 price target for the company. Evercore ISI set a $56.00 price target on shares of Imperva and gave the stock a buy rating in a research report on Friday, February 9th. Piper Jaffray upgraded shares of Imperva from a neutral rating to an overweight rating and set a $52.00 price objective for the company in a research note on Friday, February 9th. Finally, Imperial Capital boosted their price objective on shares of Imperva from $50.00 to $55.00 and gave the stock an outperform rating in a research note on Friday, February 9th. Three research analysts have rated the stock with a sell rating, five have assigned a hold rating and eleven have assigned a buy rating to the company’s stock. Imperva presently has an average rating of Hold and an average price target of $53.21.

How to Become a New Pot Stock Millionaire

Shares of IMPV opened at $49.35 on Tuesday. Imperva has a fifty-two week low of $37.17 and a fifty-two week high of $52.40. The company has a market capitalization of $1,658.51, a PE ratio of -176.25, a price-to-earnings-growth ratio of 54.46 and a beta of 1.67.

Imperva (NASDAQ:IMPV) last announced its quarterly earnings results on Thursday, February 8th. The software maker reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.13. Imperva had a net margin of 7.11% and a negative return on equity of 3.28%. The firm had revenue of $91.10 million during the quarter, compared to analysts’ expectations of $91.11 million. During the same quarter in the prior year, the company earned $0.32 EPS. The company’s revenue was up 16.2% compared to the same quarter last year. research analysts expect that Imperva will post 0.03 earnings per share for the current fiscal year.

In other Imperva news, Director Anthony J. Bettencourt sold 66,037 shares of the company’s stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $46.98, for a total transaction of $3,102,418.26. Following the transaction, the director now owns 66,037 shares in the company, valued at approximately $3,102,418.26. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CRO Michael D. Mooney sold 24,454 shares of the company’s stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $47.18, for a total transaction of $1,153,739.72. Following the transaction, the executive now owns 24,454 shares in the company, valued at approximately $1,153,739.72. The disclosure for this sale can be found here. Insiders own 1.10% of the company’s stock.

A number of institutional investors have recently modified their holdings of the business. New York State Common Retirement Fund increased its stake in Imperva by 3.4% during the 3rd quarter. New York State Common Retirement Fund now owns 37,000 shares of the software maker’s stock valued at $1,606,000 after purchasing an additional 1,200 shares in the last quarter. Teachers Advisors LLC increased its stake in Imperva by 2.3% during the 4th quarter. Teachers Advisors LLC now owns 61,251 shares of the software maker’s stock valued at $2,432,000 after purchasing an additional 1,381 shares in the last quarter. American International Group Inc. increased its stake in Imperva by 8.1% during the 3rd quarter. American International Group Inc. now owns 22,454 shares of the software maker’s stock valued at $975,000 after purchasing an additional 1,679 shares in the last quarter. UBS Asset Management Americas Inc. increased its stake in Imperva by 21.4% during the 4th quarter. UBS Asset Management Americas Inc. now owns 15,301 shares of the software maker’s stock valued at $607,000 after purchasing an additional 2,700 shares in the last quarter. Finally, GSA Capital Partners LLP increased its stake in Imperva by 24.2% during the 3rd quarter. GSA Capital Partners LLP now owns 14,630 shares of the software maker’s stock valued at $635,000 after purchasing an additional 2,846 shares in the last quarter.

ILLEGAL ACTIVITY WARNING: “Imperva (IMPV) Lifted to “Buy” at BidaskClub” was published by Week Herald and is owned by of Week Herald. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of international copyright & trademark laws. The correct version of this piece of content can be accessed at https://weekherald.com/2018/04/21/imperva-impv-lifted-to-buy-at-bidaskclub.html.

About Imperva

Imperva, Inc engages in the development, market, sale, and support of cyber security solutions that protect business critical data and applications in the cloud or on premises worldwide. The company's SecureSphere product line provides database, file, and Web application security in various data centers, including on-premises data centers, as well as in private, public, and hybrid cloud computing environments.

Analyst Recommendations for Imperva (NASDAQ:IMPV)

Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply